FDA will likely pull epinephrine inhalers (Primatene Mist, etc) off the market

FDA will likely pull epinephrine inhalers (Primatene Mist, etc) off the market.

FDA advisors now say that OTC epinephrine inhalers DON'T offer an important health benefit...and SHOULDN'T be exempt from the ban on CFC propellants.

Wyeth is trying to reformulate Primatene Mist. But it could take 5 years for the new version to be tested and approved.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote